Select Bibliography

Filter by any of these (after searching):

Barton, Debra

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 17 items

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9

Barton, Debra L. , Burger, Kelli , Novotny, Paul J. , Fitch, Tom R. ... - - Support Care Cancer - 2013

Manuscript - Primary - Primary - Symptom Inter - N00C9

Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance)

Barton, Debra L. , Shuster, Lynne T. , Dockter, Travis ... - - Support Care Cancer - 2018

Manuscript - Secondary - Primary - Symptom Inter - N10C1

Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance)

Barton, Debra L. , Sloan, Jeff A. , Shuster, Lynne T. , Gill, Paula ... - - Support Care Cancer - 2018

Manuscript - Primary - Primary - Symptom Inter - N10C1

Impact of vaginal dehydroepiandosterone (DHEA) on vaginal symptoms in female cancer survivors: Trial N10C1 (Alliance)

Barton, Debra L. , Sloan, Jeff A. , Shuster, Lynne T , Gill, Paula ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Symptom Inter - N10C1

Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA

Barton, Debra L. , Soori, Gamini S. , Bauer, Brent A. ... - - Support Care Cancer - 2010

Manuscript - Primary - Primary - Symptom Inter - N03CA

Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy, NCCTG N08C3 (Alliance)

Barton, Debra L. , Thanarajasingam, Gita , Sloan, Jeff A. ... - - Cancer - 2014

Manuscript - Primary - Primary - Symptom Inter - N08C3

A randomized phase II trial evaluating two non-pharmacologic interventions in cancer survivors for the treatment of sleep-wake disturbances: NCCTG N07C4 (Alliance)

Barton, Debra L , Atherton, Pamela J , Satele, Daniel V , Qin, Rui ... - - Support Care Cancer - 2020

Manuscript - Primary - Primary - Symptom Inter - NCCTG-N07C4

Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.

Barton, Debra L , Wender, Donald B , Sloan, Jeff A , Dalton, Robert J ... - - J. Natl. Cancer Inst. - 2007

Manuscript - Primary - Primary - Symptom Inter - NCCTG-N02C3

Addressing the Complexities of Sexual Health in Female Cancer Survivors: NCCTG N10C1 (Alliance)

Barton, Debra , Dockter, Travis , Atherton, Pamela , Lester, Joanne ... - CANS - - 2014

Abstract - Secondary - Primary - Symptom Inter - N10C1

A Pilot Randomized, Placebo Controlled, Double Blind Study of Omega-3 Fatty Acids to Prevent Paclitaxel Associated Acute Pain Syndrome

Dayao, Zoneddy , Brown-Glabermann, Ursa , Chen, Lu , Pankratz, Shane ... - ASCO - J Clin Oncol - 2020

Abstract - Primary - Primary - Symptom Inter - Pilot

Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance)

Kottschade, Lisa , Novotny, Paul , Lyss, Alan , Mazurczak, Miroslaw ... - - Support Care Cancer - 2016

Manuscript - Secondary-not-in-original - Primary - Symptom Inter - N08C3

A randomized, double-blind, placebo-controlled trial of testosterone (T) for aromatase inhibitor-induced arthralgias (AIA) in postmenopausal women: Alliance study A221102

Leon-Ferre, Roberto A. , Novotny, Paul , Terstriep, Shelby ... - SABCS - Cancer Res - 2019

Abstract - Primary - Primary - Symptom Inter - A221102

Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5.

Loprinzi, Charles L , Kugler, John W , Barton, Debra L ... - - J. Clin. Oncol. - 2007

Manuscript - Primary - Primary - Symptom Inter - N03C5

Randomized Clinical Trial of Imiquimod: An Adjunct to Treating Cervical Dysplasia

Pachman, Deirdre R. , Barton, Debra L. , Clayton, Amy H. ... - - Am J Obstet Gynecol - 2012

Manuscript - Primary - Primary - Prevention - NCCTG-989251

NCCTG N10C2 (Alliance) – A Double-Blind, Placebo-Controlled Study of Magnesium Supplements to Reduce Menopausal Hot Flashes

Park, Haeseong , Qin, Rui , Smith, Thomas J. , Atherton, Pamela J. ... - - Menopause - 2015

Manuscript - Primary - Primary - Symptom Inter - N10C2

NCCTG N10C2 (Alliance): A double-blind, placebo-controlled study of magnesium supplements to reduce menopausal hot flashes

Park, Haeseong , Qin, Rui , Smith, Thomas J. , Atherton, Pamela J. ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary - Primary - Symptom Inter - N10C2

A Phase III, Randomized, Placebo-Controlled, Double-Blind Trial of Flaxseed for the Treatment of Hot Flashes1:NCCTG N08C7

Pruthi, Sandhya , Qin, Rui , Terstreip, Shelby A. , Liu, Heshan ... - - Menopause - 2012

Manuscript - Primary - Primary - Symptom Inter - N08C7